KTTA (Pasithea Therapeutics Corp.) Koefisien nilai perusahaan marang pendapatan

Pasithea Therapeutics Corp (KTTA) - logo korporat

The lack of stable income and risks associated with psychiatric research are weighing on shares, and consequently, the EV-to-revenue ratio on GURU.Markets reflects current volatility, with the value holding at 0.00. The prospects for Pasithea Therapeutics (KTTA) rely on the success of macrophage inhibitors and M&A potential, while updated management strictly controls operating expenses to preserve liquidity.

Pasithea - Multiplikator EV/Sales KTTA (periode 23.11.2025 - 20.11.2026)

Pasithea Therapeutics - rincian analitis lan metrik utama (KTTA)

- indikator valuasi pasar bisnis:
Analisis wiwitan perusahaan:Pasithea Therapeutics Corp
Sampel barang Pasithea

The balance between developing ketamine therapy clinics and creating neurofibromatosis drugs allows Pasithea Therapeutics (KTTA) to diversify its cash flows. By analyzing the enterprise value-to-sales multiple, an investor assesses the market value of the business, including debt, relative to revenue, where a sharp increase in the indicator signals inflated growth expectations and the risk of overpayment, calling into question the sustainability of the invested capital.

Analisis pesaing Pasithea Therapeutics

BIIB (Biogen Inc.) - Rasio nilai perusahaan marang pendapatan|NBIX: Multiplikator EV/Sales|RGC (Regencell Bioscience Holdings Limited) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Axsome Therapeutics Inc|ACAD: Nilai bisnis marang pendapatan|Multiplikator EV/Sales XENE|Multiplikator EV/Sales vikingtherapeutics.com (VKTX)|Rasio nilai perusahaan marang pendapatan Supernus SUPN|Nilai bisnis marang pendapatan CPRX|denalitherapeutics.com - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan Harmony Pharma HRMY|BHVN: Multiplikator EV/Sales|Multiplikator nilai perusahaan marang pendapatan Amylyx Pharmaceuticals, Inc. (AMLX)|TRVI (Trevi Therapeutics Inc) - Multiplikator EV/Sales|Rasio nilai perusahaan marang pendapatan PRAX (Praxis Medicines)|Rasio nilai perusahaan marang pendapatan Anavex Life Sciences (AVXL)|Rasio nilai perusahaan marang pendapatan CBLL (CeriBell EEG)|Multiplikator EV/Sales PRTA (Prothena Corp)|alector.com (ALEC) - Multiplikator nilai perusahaan marang pendapatan|ANNX: Nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Omeros|NGNE: Multiplikator EV/Sales|Nilai perusahaan marang pendapatan AC Immune|Nilai perusahaan marang pendapatan VYGR|Rasio nilai perusahaan marang pendapatan NMRA (neumoratx.com)|Nilai perusahaan marang pendapatan SCLX (Scilex Holding Company, Inc.)|Rasio nilai perusahaan marang pendapatan TVGN (Tevogen Bio)|Rasio nilai perusahaan marang pendapatan Alpha Cognition ACOG|CGTX - Nilai perusahaan marang pendapatan|IKT - Rasio nilai perusahaan marang pendapatan|SAVA: Rasio nilai perusahaan marang pendapatan|Assertio Therapeutics (ASRT) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Coya Therapeutics Inc (COYA)|Rasio nilai perusahaan marang pendapatan Vistagen|Rasio nilai perusahaan marang pendapatan OVID (ovidrx.com)|Rasio nilai perusahaan marang pendapatan Acumen Pharmaceuticals, Inc. (ABOS)|CRVO - Multiplikator nilai perusahaan marang pendapatan|Alterity Therapeutics Ltd. - Nilai perusahaan marang pendapatan|CLNN - Nilai perusahaan marang pendapatan|PEPG - Rasio nilai perusahaan marang pendapatan|Rasio total nilai perusahaan marang pendapatan jupiterneurosciences.com JUNS|Relmada Therapeutics (RLMD) - Rasio nilai perusahaan marang pendapatan|ANVS (Annovis Bio, Inc.) - Rasio nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan gracetx.com|Multiplikator EV/Sales Firefly Neuroscience, Inc.|Rasio nilai perusahaan marang pendapatan ANEW Medical (KLTO)|NRSN - Multiplikator nilai perusahaan marang pendapatan|Multiplikator EV/Sales RVPH (Reviva Pharmaceuticals Holdings Inc.)|Koefisien nilai perusahaan marang pendapatan MTVA (metaviatx.com)|NeurAxis Inc. - Multiplikator EV/Sales|Rasio total nilai perusahaan marang pendapatan heliusmedical.com HSDT|PASG: Multiplikator EV/Sales|Neuphoria - Nilai bisnis marang pendapatan|Nilai perusahaan marang pendapatan NERV|ATHA: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Addex Therapeutics Ltd (ADXN)|ALZN (Alzamend Neuro Inc.) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales CYCN (cyclerion.com)|Rasio nilai perusahaan marang dodolan Protagenic|CRGT - Rasio nilai perusahaan marang pendapatan|Nilai bisnis marang pendapatan ATXI (Avenue Therapeutics)|BCLI: Multiplikator EV/Sales|Cara Therapeutics - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Chromocell Therapeutics Corporation|Multiplikator EV/Sales Eliem Therapeutics Inc.|Rasio nilai perusahaan marang pendapatan Intra-Cellular Therapies, Inc. (ITCI)|LBPH (Longboard Pharmaceuticals) - Nilai bisnis marang pendapatan|Multiplikator EV/Sales MRNS (marinuspharma.com)|NKGN: Rasio nilai perusahaan marang pendapatan|NRBO - Rasio nilai perusahaan marang pendapatan|SAGE - Multiplikator EV/Sales|Synaptogenix (SNPX) - Rasio nilai perusahaan marang pendapatan|Multiplikator nilai perusahaan marang pendapatan Trevena (TRVN)|Nilai perusahaan marang pendapatan VIGL|Rasio nilai perusahaan marang pendapatan WENA (Anew Medical)|Multiplikator EV/Sales CERE